Elevai Labs Enters into Licensing Agreement with Yuva Biosciences to Combine Exosome and Mitochondrial Technologies to Develop New Aesthetics Products

Elevai Labs, Inc. announced that they have signed a licensing agreement with Yuva Biosciences, Inc. to research and develop means to incorporate Yuva Bioscience’s mitochondrial research with ELEVAI’s PREx™ to potentially develop topical skincare formulations that combine mitochondrial biology with Elevai’s human umbilical MSC-derived exosomes.